immune system
|
• worse than in Faslpr homozygotes
|
|
• increased faster in the blood and to a higher proportion than in Faslpr homozygotes
|
|
• decreased circulating B cells for the first 13 weeks of age compared with Faslpr homozygotes
|
|
• from 19 weeks compared with Faslpr homozygotes
|
|
• from 19 weeks compared with Faslpr homozygotes
|
|
• worse than in Faslpr homozygotes
|
|
• more severe autoimmune disease development with inflammatory cell infiltration of the kidney and hypertrophy in the lymphoid organs compared with Faslpr homozygotes
|
|
• compared with Faslpr homozygotes
|
|
• compared with Faslpr homozygotes
|
homeostasis/metabolism
|
• compared with Faslpr homozygotes
|
renal/urinary system
|
• compared with Faslpr homozygotes
|
hematopoietic system
|
• worse than in Faslpr homozygotes
|
|
• increased faster in the blood and to a higher proportion than in Faslpr homozygotes
|
|
• decreased circulating B cells for the first 13 weeks of age compared with Faslpr homozygotes
|
|
• from 19 weeks compared with Faslpr homozygotes
|
|
• from 19 weeks compared with Faslpr homozygotes
|
growth/size/body
|
• worse than in Faslpr homozygotes
|


Analysis Tools